Pharmafile Logo

Insights

- PMLiVE

ABPI explores the future of medicines

Predicts inhalable nanobots and 3D printed medicine patches

- PMLiVE

Why can’t we use Google Maps to understand patient journeys?

Patient experiences are diverse and dynamic. Mapping patient journeys enables us to unlock salient insights and redesign care pathways.

Porterhouse Medical Group

- PMLiVE

Rigel and Ultragenyx claim approvals for rare drugs

Tavalisse and Crysvita are set to treat patients with chronic ITP and XLH, respectively

Bristol-Myers Squibb (BMS) building

BMS claims rapid FDA nod for Opdivo plus Yervoy in kidney cancer

Data shows the combo can improve survival compared to Pfizer’s Sutent

- PMLiVE

Artificial intelligence in healthcare ‘set for 40% growth to 2024’

And the US, the UK and China are all expected to be front-runners

- PMLiVE

Beyond caring: learning from the unsung advocates in cancer care

Macmillan Cancer Support estimates that there are currently around 1.5 million carers caring for someone who has cancer in the UK. Broadly, carers in and outside cancer contribute around £132...

The two ‘c’s’ of public health: confounding and causal inference*

Rerum cognoscere causas. This phrase translates as ‘to know the causes of things’. It is the basis and impetus of public health. But epidemiologists have a different word for it:...

- PMLiVE

A new era of smart pharma

How smarter pharmaceuticals and pharmacovigilance are transforming healthcare

- PMLiVE

Health insurers will test blockchain for data handling

Aims to make health records more accurate and reliable

- PMLiVE

The Patient Safety Challenge

Understanding the causes of medication  errors and how to reduce them

- PMLiVE

Alkermes slumps as FDA turns down depression drug

The drug needs to be supported with additional trials and a bioavailability study, says US regulator

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links